In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sangamo Therapeutics Inc (NASDAQ: SGMO) closed the day trading at $2.01 up 2.03% from the previous closing price of $1.97. In other words, the price has increased by $2.03 from its previous closing price. On the day, 4.17 million shares were traded. SGMO stock price reached its highest trading level at $2.075 during the session, while it also had its lowest trading level at $1.92.
Ratios:
For a better understanding of SGMO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.71.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on November 03, 2023, Downgraded its rating to Sector Perform and sets its target price to $2 from $6 previously.
On April 28, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $5 to $1.50.
Wedbush Upgraded its Neutral to Outperform on February 27, 2023, while the target price for the stock was maintained at $16.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMO now has a Market Capitalization of 419380480 and an Enterprise Value of 407299456. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.18 while its Price-to-Book (P/B) ratio in mrq is 10.71. Its current Enterprise Value per Revenue stands at 7.789 whereas that against EBITDA is -3.48.
Stock Price History:
Over the past 52 weeks, SGMO has reached a high of $3.18, while it has fallen to a 52-week low of $0.30. The 50-Day Moving Average of the stock is 21.32%, while the 200-Day Moving Average is calculated to be 118.03%.
Shares Statistics:
Over the past 3-months, SGMO traded about 7.38M shares per day on average, while over the past 10 days, SGMO traded about 5016110 shares per day. A total of 208.62M shares are outstanding, with a floating share count of 199.07M. Insiders hold about 4.59% of the company’s shares, while institutions hold 27.00% stake in the company. Shares short for SGMO as of 1731628800 were 13391232 with a Short Ratio of 1.82, compared to 1728950400 on 18220713. Therefore, it implies a Short% of Shares Outstanding of 13391232 and a Short% of Float of 6.45.